Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin in Hepatorenal Syndrome Type 1
NCT00089570Phase 3Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Jun 2004
- Primary completion
- Mar 2006
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hepatorenal syndrome type 1 (HRS-1) comparing Terlipressin Arm with Placebo Arm (2 arms). Primary endpoint: Treatment Success at Day 14. Started Jun 2004; status: completed.
02
Drugs
terlipressin
03
Conditions
hepatorenal syndrome type 1 (HRS-1)
Beyond the preview
Go deeper on NCT00089570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089570.